Donald W. DeGolyer, Director at Emergent BioSolutions Inc. (EBS), sold 25,000 shares at $10.91 ($273K) on 2024-11-12, disclosed to the SEC on 2024-11-14.
Open-market sale of $273k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2025-08-13 | $136K | — | Filing → |